Paper2302723
Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.
Knisely TL and 1 other. Cancer Immunol Immunother, 1990. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye. Papers, record 2302723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2302723
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anterior Chamber | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Eye Neoplasms | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Animals | |
| Cell Separation | |
| Female | |
| Flow Cytometry | |
| Graft Rejection | |
| Histocompatibility Antigens Class II | |
| Hypersensitivity, Delayed | |
| Macrophages | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Neoplasm Transplantation | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA030276 | NCI NIH HHS | United States | R01CA030276 | PubMed and NIH | NIH RePORTER |
| R37 CA030276 | NCI NIH HHS | United States | R01CA030276 | PubMed and NIH | NIH RePORTER |
| EYO5631 | NEI NIH HHS | United States | PubMed | PubMed | |
| CA30276 | NCI NIH HHS | United States | R01CA030276 | PubMed and NIH | NIH RePORTER |
| R37CA030276 | NIH | NIH RePORTER |
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1084897 | Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. | J Immunol | 1976 | https://conductscience.org/library/papers/1084897 | PubMed |
| 2 | 3875569 | Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells. | Int J Cancer | 1985 | https://conductscience.org/library/papers/3875569 | PubMed |
| 3 | 6403609 | Recombinant interferon-gamma increases HLA-DR synthesis and expression. | J Immunol | 1983 | https://conductscience.org/library/papers/6403609 | PubMed |
| 4 | 6980254 | Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. | J Exp Med | 1982 | https://conductscience.org/library/papers/6980254 | PubMed |
| 5 | 6195085 | Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. | Immunol Rev | 1983 | https://conductscience.org/library/papers/6195085 | PubMed |
| 6 | 3024832 | Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3024832 | PubMed |
| 7 | 301897 | Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas. | J Immunol | 1977 | https://conductscience.org/library/papers/301897 | PubMed |
| 8 | 6996909 | Separation of individual kinds of cells from tumors. | Contemp Top Immunobiol | 1980 | https://conductscience.org/library/papers/6996909 | PubMed |
| 9 | 6776227 | Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. | J Exp Med | 1980 | https://conductscience.org/library/papers/6776227 | PubMed |
| 10 | 7009746 | Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. | J Immunol | 1981 | https://conductscience.org/library/papers/7009746 | PubMed |
| 11 | 3029221 | Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. | J Immunol | 1987 | https://conductscience.org/library/papers/3029221 | PubMed |
| 12 | 300075 | Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo. | Int J Cancer | 1977 | https://conductscience.org/library/papers/300075 | PubMed |
| 13 | 11515089 | Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. | J Natl Cancer Inst | 1970 | https://conductscience.org/library/papers/11515089 | PubMed |
| 14 | 6227669 | Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells. | J Immunol | 1983 | https://conductscience.org/library/papers/6227669 | PubMed |
| 15 | 2783319 | Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. | J Immunol | 1989 | https://conductscience.org/library/papers/2783319 | PubMed |
| 16 | 316708 | Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. | Br J Cancer | 1979 | https://conductscience.org/library/papers/316708 | PubMed |
| 17 | 6282973 | Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature. | J Immunol | 1982 | https://conductscience.org/library/papers/6282973 | PubMed |
| 18 | 3108394 | Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. | J Immunol | 1987 | https://conductscience.org/library/papers/3108394 | PubMed |
| 19 | 3855286 | Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. | Cancer Res | 1985 | https://conductscience.org/library/papers/3855286 | PubMed |
| 20 | 3260908 | Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma. | J Immunol | 1988 | https://conductscience.org/library/papers/3260908 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33194647 | Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/33194647 | PubMed |
| 31750244 | Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets. | Front Oncol | 2019 | https://conductscience.org/library/papers/31750244 | PubMed |
| 22693246 | IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact. | J Leukoc Biol | 2012 | https://conductscience.org/library/papers/22693246 | PubMed |
| 21918192 | IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. | J Immunol | 2011 | https://conductscience.org/library/papers/21918192 | PubMed |
| 20482389 | Immune privilege of corneal allografts. | Ocul Immunol Inflamm | 2010 | https://conductscience.org/library/papers/20482389 | PubMed |
| 19563908 | Immune escape mechanisms of intraocular tumors. | Prog Retin Eye Res | 2009 | https://conductscience.org/library/papers/19563908 | PubMed |
| 17944931 | CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages. | Immunology | 2008 | https://conductscience.org/library/papers/17944931 | PubMed |
| 1937568 | In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber. | Immunology | 1991 | https://conductscience.org/library/papers/1937568 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2302723
GET https://conductscience.org/api/papers/v1/2302723/references?page=2